Clinical end points after 1-year follow-up
| End point | NCB cohort (n=53) | SCB cohort (n=51) | P value |
| Death | 1 (1.89%) | 0 (0%) | – |
| Stroke | 0 (0%) | 0 (0%) | – |
| Myocardial infarction | 0 (0%) | 1 (2%) | – |
| Target vessel revascularisation | 0 (0%) | 1 (2%) | – |
| Non-target vessel revascularisation | 0 (0%) | 2 (4%) | – |
| Stent thrombosis | 0 (0%) | 0 (0%) | – |
NCB, non-compliant balloon; SCB, semi-compliant balloon.